Magnolia Capital Advisors’s AbbVie ABBV Stock Holding History

Magnolia Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.21M	Buy	16,722 +1,835	+12%	+$395K	0.72%	41
2026 Q1	$3.24M	Buy	14,887 +4,684	+46%	+$1.04M	0.64%	48
2025 Q4	$2.33M	Buy	10,203 +42	+0.4%	+$9.57K	0.49%	52
2025 Q3	$2.35M	Buy	10,161 +162	+2%	+$33K	0.61%	43
2025 Q2	$1.86M	Buy	9,999 +7,231	+261%	+$1.34M	0.47%	54
2025 Q1	$580K	Sell	2,768 -1,266	-31%	-$246K	0.16%	145
2024 Q4	$717K	Buy	+4,034	New	+$742K	0.19%	126
2024 Q2	–	Sell	-4,885	Closed	-$813K	–	122
2024 Q1	$813K	Buy	4,885 +1,441	+42%	+$248K	0.68%	45
2023 Q4	$568K	Sell	3,444 -148	-4%	-$21.6K	0.41%	64
2023 Q3	$510K	Buy	3,592 +48	+1%	+$7.05K	0.49%	46
2023 Q2	$477K	Sell	3,544 -3	-0.1%	-$440	0.24%	88
2023 Q1	$565K	Buy	3,547 +438	+14%	+$67K	0.29%	83
2022 Q4	$502K	Buy	+3,109	New	+$477K	0.33%	82
2022 Q3	–	Sell	-1,316	Closed	-$201K	–	126
2022 Q2	$201K	Sell	1,316 -477	-27%	-$72.9K	0.18%	114
2022 Q1	$291K	Sell	1,793 -206	-10%	-$29.9K	0.11%	139
2021 Q4	$271K	Sell	1,999 -23	-1%	-$2.72K	0.08%	162
2021 Q3	$218K	Buy	+2,022	New	+$231K	0.08%	169
2021 Q2	–	Sell	-2,057	Closed	-$223K	–	143
2021 Q1	$223K	Buy	+2,057	New	+$220K	0.44%	68

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Magnolia Capital Advisors's ABBV Position: Q2 2026 in Review

Magnolia Capital Advisors increased its AbbVie (ABBV) stake by 12% in Q2 2026, buying an estimated $395K and bringing the position to 16,722 shares worth $4.21M. The position accounts for 0.72% of the portfolio, ranked #41.

Magnolia Capital Advisors first reported a position in ABBV in Q1 2021 and has held it in 18 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Magnolia Capital Advisors held 16,722 shares of AbbVie worth $4.21M as of Q2 2026.
Magnolia Capital Advisors bought 1,835 AbbVie shares in Q2 2026, an estimated $395K.
AbbVie made up 0.72% of Magnolia Capital Advisors's portfolio in Q2 2026, its #41 holding.
Magnolia Capital Advisors first reported a position in AbbVie in Q1 2021 and has held it in 18 quarters since.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Magnolia Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.